NCT02664961 2019-07-23Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN)Tracon Pharmaceuticals Inc.Phase 2 Terminated3 enrolled 11 charts
NCT00190918 2007-08-09A Trial for Patients With Gestational Trophoblastic DiseaseEli Lilly and CompanyPhase 2 Completed50 enrolled